Company Information

CIN
Status
Date of Incorporation
26 September 1979
State / ROC
Hyderabad / ROC Hyderabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2022
Paid Up Capital
150,000,000
Authorised Capital
150,000,000

Directors

Neeharika Makkuva
Neeharika Makkuva
Director/Designated Partner
over 2 years ago
Shankar Prasad Tatambhotla
Shankar Prasad Tatambhotla
Director/Designated Partner
over 2 years ago

Past Directors

Pramod Anand Krishna Tatambhotla
Pramod Anand Krishna Tatambhotla
Additional Director
over 11 years ago
Tatambhotla Sitaram Anjaneyulu
Tatambhotla Sitaram Anjaneyulu
Director
over 36 years ago

Patents

A Process For The Preparation Of Benzoic Anhydride From Benzoic Acid

The present invention relates to an industrially applicable process for preparing benzoic anhydride from benzoic acid using bi-phase condition.

A Process For Recovery Of Benzoic Acid From Benzoylation Reaction

Ab8tract:                                                     700127709 The present invention relates to an ecofriendly process for recovering benzoic acid from benzoylation reaction.

A Process For The Preparation Of 2', 4" Di O Benzoyl 11 N (4 Azidobutyl) 6 O Methylerythromycin And Its Impurity

The present invention relates to industrially feasible and safe process for preparing 2",4"-di-O-benzoyl-1 l-N-(4-Azidobutyl)-6-0-methy(erythromycin and its impurity.

A Process For The Preparation Of Azidoalkylamine And Its Various Salts

The present invention relates to the process for the preparation of azidoalkylamine and its various salts.

A Process For The Preparation Of Clarithromycin Benzoate Derivatives

The present invention relates to insitu process for the preparation of 2\4"-di-o-benzoyl-6-o- methyl erythromycin.

An Improved Process For Preparing 10, 11 Dihydro 10 Oxo5 H Dibenz [B,F]Azepine 5 Carboxamide

The present invention relates to advantageous process for the~~pTeparauon of 10,1 l-Dihydro-10-oxo5H-dibenz[b,f]azepine-5-carboxamide and its intermediate.

An Advantageous Process For Preparation Of S Isomer Of Mirabegron

The present invention relates to an improved process for the preparation of S-isomer of Mirabegron.

A Process For Preparation Of Doxazosin Intermediate And Novel Impurity

The present invention relates to an improved process for the preparation of doxazosin intermediate and novel impurity.

An Advantageous Process For Preparation Of 6,7 Dimethoxy 2 (Piperazin L Yl)quinazolin 4 Amine

NOT SUBMITTED

An Advantageous Process For Preparation Of Di Tert Butylchloromethylphosphate

The present invention relates to advantageous, safe and robust process for preparing Di tertbutylchloromethylphosphate of formula-1.

An Improved Process For Preparing 5 Aminolevulinic Acid Hydrochloride And Its Novel Intermediates

The present invention relates to an improved, robust and industrially feasible process for preparing 5-Aminolevulinic acid hydrochloride and its novel intermediates.

An Improved Process For Preparing 5 Aminolevulinic Acid Hydrobromide

The present invention relates to an improved process for preparing acid addition salt of 5-aminolevuiinic acid.

An Improved Process For Preparing Aminoacetaldehyde Dimethyl Acetal

The present invention relates to advantageous, industrially applicable process for preparing Aminoacetaldehyde dimethyl acetal.

An Improved Process For Preparing 5 {2 [4 (1,2 Benzisothiazol 3 Yl)piperazin 1 Yl]Ethyl} 6 Chloro 1,

Soft Copy Attached in PDF

An Advantageous Process For Preparation Of Erythromycin, 9 [O (1 Methoxy 1 Methylethyl)oxime], 2'',4" Dibenzoate

An advantageous process for preparing Erythromycin, 9-[O-(1-methoxy-1-methylethyl)oxime], 2",4"-dibenzoate by using weak acidic catalyst.

An Improved And Safe Process For Preparation Of Dabigatran Intermediates

The present invention relates to an improved process for preparing ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzainido)propanoate of Formula 3. It is a key intermediate to prepare Dabigatran of Formula-1 and Dabigatran etexilate of Formula-2. The present invention relates to safe, economical, robust and ind...

An Advantageous Process For Preparing (S) Ethyl 3 Cyano 5 Methylhexanoate

The present invention relates to improved, safe and industrially applicable enantioseleclive enzymatic process for preparing (S)-Ethyl-3-cyano-5-methylhexanoate
The present invention relates to an improved purification process for l-(3-(trif!uoromethyI)-5>6-dihydro-[l)254]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyI)butane-l,3-dione of formula-2. Moreover, the present invention provides robust, industrially applicable process for preparing l-(3-(trifluoromethyl...

An Improved Enzymatic Process For Preparing Sitagliptin Phosphate

The present invention relates to an advantageous, commercially viable, industrially feasible process for preparing 7-[(3R)-3-amino-l-oxo-4-(2)4)5-trifluorophenyl) butyl]-5,6,758-tetrahydro-3- (trifluoromethy^-l^^-triazolo^S-a] pyrazine phosphate monohydrate of formula-2 and its purification.

A Novel Process For Preparng (S) 3 (4 (2 Chloro 5 Iodobenzyl)phenoxy)tetrahydrofuran

The present invention relates to an advantageous, industrially feasible process for preparing (S)-3-(4-(2-chloro-5-iodobenzyl)phenoxy) tetrahydrofuran.
The present invention relates to improved, advantageous, safe, robust process for preparing 1-[[2'-(2,5-dihydro-5-oxo-l,2,4-oxadiazol-3-yl)[l,r-biphenyl]-4-yl]methyl]-2-ethoxy-lH-benzimidazole-7-carboxylic acid of formula-1 comprises;

An Improved Process For Preparing 2 Isobutylsuccinic Acid

The present invention relates to an improved process for preparing novel impurity of pregabalin of formula-2.

An Improved Process For Preparing 3 Isobutylpyrrolidine 2,5 Dione

The present invention relates to an improved process for preparing new impurity of pregabalin of formula-2.

An Improved Process For Preparing 2 Deoxy D Glucose

Not Submitted.

An Improved Process For Preparing 2 Deoxy D Glucose

Not Submitted

An Improved Process For Preparing Isopropyl Ethyl Amine

The present invention relates to an improved process for preparing ethylisopropyl amine and N-(dihaloethyl) propyl-2-amine.

An Improved Process For Preparing Sodium (2 S, 5 R) 2 Carbamoyl 7 Oxo 1, 6 Diazabicyclo[3.2.1] Octan 6 Yl Sulfate And Intermediates.

The present invention relates to process for the preparation of sodium [(2S,5R)-2-carbamoyl-7-oxo-l,6-diazabicyclo[3.2.1]octan-6-yl] sulfate of formula-1

An Improved Process For Preparing Sodium (2 S,5 R) 2 Carbamoyl 7 Oxo 1, 6 Diazabicyclo[3.2.1]Octan 6 Yl Sulfate And Intermediates

Soft Copy Attached in PDF

A Process For Preparing Non Pharmacopoeial Impurities Of (3 S) 3 (Aminomethyl) 5 Methylhexanoic Acid.

The present invention relates to process for preparing non-pharmacopoeial impurities 3-carbamoyl-5-methylhexanoic acid of formula-2 and 2-(2-amino-2-oxoethyl)-4-methylpentanoic acid of formula-3

Charges

13 Crore
12 June 2002
State Bank Of India
12 Crore
25 July 1996
State Bank Of Hyderabad
50 Lak
28 September 1992
State Bank Of Hyderabad
45 Lak
07 August 1990
A.p. State Financial Corporation
1 Lak
22 July 1987
State Bank Of Hyderabad
21 Lak
25 June 1985
State Bank Of Hyderabad
19 Lak
07 September 1981
State Bank Of Hyderabad
2 Lak
13 June 1980
State Bank Of Hyderabad
2 Lak
27 March 1980
Andhra Pradesh State Financial Corporation
7 Lak
12 June 2002
State Bank Of India
0
25 July 1996
State Bank Of Hyderabad
0
25 June 1985
State Bank Of Hyderabad
0
07 August 1990
A.p. State Financial Corporation
0
07 September 1981
State Bank Of Hyderabad
0
27 March 1980
Andhra Pradesh State Financial Corporation
0
28 September 1992
State Bank Of Hyderabad
0
22 July 1987
State Bank Of Hyderabad
0
13 June 1980
State Bank Of Hyderabad
0
12 June 2002
State Bank Of India
0
25 July 1996
State Bank Of Hyderabad
0
25 June 1985
State Bank Of Hyderabad
0
07 August 1990
A.p. State Financial Corporation
0
07 September 1981
State Bank Of Hyderabad
0
27 March 1980
Andhra Pradesh State Financial Corporation
0
28 September 1992
State Bank Of Hyderabad
0
22 July 1987
State Bank Of Hyderabad
0
13 June 1980
State Bank Of Hyderabad
0

Documents

Form ADT-1-17122020_signed
Copy of written consent given by auditor-15122020
Copy of the intimation sent by company-15122020
Copy of resolution passed by the company-15122020
Form CHG-1-01102020_signed
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20200930
Optional Attachment-(1)-29092020
Instrument(s) of creation or modification of charge;-29092020
Form AOC-4(XBRL)-22012020_signed
Statement of subsidiaries as per section 129-Form AOC-1 (To be attached in respect of Foreign subsidiaries)-17012020
Optional Attachment-(1)-17012020
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-17012020
XBRL document in respect Consolidated financial statement-17012020
Form MGT-7-06012020_signed
List of share holders, debenture holders;-31122019
Form ADT-1-23112019_signed
Copy of resolution passed by the company-23112019
Copy of the intimation sent by company-23112019
Copy of written consent given by auditor-23112019
Form MGT-7-10042019_signed
XBRL document in respect Consolidated financial statement-04042019
Statement of subsidiaries as per section 129-Form AOC-1 (To be attached in respect of Foreign subsidiaries)-04042019
Copy of MGT-8-04042019
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-04042019
Optional Attachment-(1)-04042019
List of share holders, debenture holders;-04042019
Form AOC-4(XBRL)-04042019_signed
Form DIR-12-22012019_signed
Evidence of cessation;-20012019
Form MGT-7-17042018_signed